Virus Res 2007,126(1–2):9–18.PubMedCrossRef 26. Zeng J, Joo HM, Rajini B, Wrammert JP, Sangster MY, Onami TM: The generation of influenza-specific humoral responses is impaired in ST6Gal I-deficient mice. J Immunol 2009,182(8):4721–4727.PubMedCentralPubMedCrossRef 27. Gambaryan A, Tuzikov A, Pazynina G, Webster R, Matrosovich M, Bovin N: H5N1 chicken influenza
viruses display a high binding affinity for Neu5Acalpha2–3Galbeta1–4(6-HSO3)GlcNAc-containing receptors. Virology 2004,326(2):310–316.PubMedCrossRef 28. Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S: Mouse β-galactoside α2, 3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 1997,7(4):469–479.PubMedCrossRef 29. Kono M, Takashima S, Liu H, Inoue M, Kojima N, Young-Choon L, Hamamoto T, Tsuji S: Molecular
KPT330 cloning and functional expression of a fifth-type α2, 3-sialyltransferase (mST3Gal V: GM3 synthase). Biochem Biophys Res Commun 1998,253(1):170–175.PubMedCrossRef 30. Gambaryan A, Robertson J, Matrosovich M: Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 1999,258(2):232–239.PubMedCrossRef 31. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, van Riel D, Schrauwen EJA, Bestebroer TM, Koel B, Burke DF: Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A (H1N1) virus affects receptor binding. J Virol 2010,84(22):11802–11813.PubMedCentralPubMedCrossRef selleck inhibitor 32. Schwardt O, Gao GP, Visekruna T, Rabbani S, Gassmann E, Ernst DB: Substrate specificity and preparative use of recombinant rat ST3Gal III. J Carbohydr Chem 2004,23(1):1–26.CrossRef 33. Description of α2,3-(O)-sialyltransferase, rat, recombinant, S. frugiperda [http://www.millipore.com/catalogue/item/566227–100miu#] 34. Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, Basler CF, Taubenberger Tau-protein kinase JK, Palese P: A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 2005,79(17):11533–11536.PubMedCentralPubMedCrossRef 35. Monteerarat Y, Suptawiwat O, Boonarkart C, Uiprasertkul
M, Auewarakul P, Viprakasit V: Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specific sialyltransferase. Arch Virol 2010,155(6):889–893.PubMedCrossRef 36. BLOCK-iT™ RNAi designer [http://rnaidesigner.invitrogen.com/rnaiexpress/] 37. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001,411(6836):494–498.PubMedCrossRef 38. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K: Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 2000,278(2):587–596.PubMedCrossRef 39.